Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126154261 | 12615426 | 1 | I | 200910 | 20160725 | 20160802 | 20160802 | EXP | US-ELI_LILLY_AND_COMPANY-US201607011208 | ELI LILLY AND CO | 0.00 | M | Y | 0.00000 | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126154261 | 12615426 | 1 | PS | CIALIS | TADALAFIL | 1 | Oral | UNK | U | 21368 | TABLET | ||||||||
| 126154261 | 12615426 | 2 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | UNK | 0 | ||||||||||
| 126154261 | 12615426 | 3 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126154261 | 12615426 | 1 | Erectile dysfunction |
| 126154261 | 12615426 | 2 | Erectile dysfunction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126154261 | 12615426 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126154261 | 12615426 | Malignant melanoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126154261 | 12615426 | 1 | 200909 | 200911 | 0 | |
| 126154261 | 12615426 | 2 | 200603 | 200702 | 0 | |
| 126154261 | 12615426 | 3 | 200912 | 201008 | 0 |